Overview
Mohamad Salkeni is a Hematologist Oncology specialist and a Hematologist in Woodbridge, Virginia. Dr. Salkeni is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Paget Disease of the Breast. Dr. Salkeni is currently accepting new patients.
His clinical research consists of co-authoring 21 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2280 Opitz Blvd, Suite 130, Woodbridge, VA 22191
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Skip Viragh Outpatient Cancer Center
Dr. Meyer will serve as the lead medical oncologist for adult sarcoma patients, and will focus on building the Adult Sarcoma and Connective Tissue Oncology Program. In collaboration with pediatric oncologist David Loeb, M.D., Ph.D., and orthopaedic surgeon Kristy Weber, M.D., Meyer will bring novel therapies to the clinic for sarcoma patients. Meyer received his bachelors and masters degrees in cell and molecular biology from Stanford University. From there, he joined the Medical Scientist Training Program at Baylor College of Medicine and earned his medical degree followed by a doctorate in immunology. Meyer completed his residency at the University of Maryland and served as chief resident in medicine from 2004-2005. Afterward, he joined our fellowship program in medical oncology and has been working in the laboratory of Jonathan Powell, M.D., Ph.D., on projects relating to the characterization of molecular regulatory pathways involved in T-cell activation and energy. As a third-year fellow, Meyer served as the chief fellow for our Training Programs in Hematology and Medical Oncology and he received a Young Investigator Award from the American Society of Clinical Oncology in 2010. Dr. Meyer is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Mesenchymoma, Undifferentiated Pleomorphic Sarcoma, Bone Tumor, and Ganglioneuroblastoma.
James Doroshow is an Oncologist in Bethesda, Maryland. Dr. Doroshow is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Alveolar Soft Part Sarcoma, Desmoid Tumor, Clear Cell Sarcoma, Adult Soft Tissue Sarcoma, and Tissue Biopsy.
Dennis Priebat is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Priebat is rated as a Distinguished provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Salkeni isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Salkeni isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Salkeni isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Salkeni isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Familial Colorectal CancerDr. Salkeni isAdvanced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Salkeni isAdvanced. Learn about Familial Pancreatic Cancer.
- Pancreatic CancerDr. Salkeni isAdvanced. Learn about Pancreatic Cancer.
- PancreatoblastomaDr. Salkeni isAdvanced. Learn about Pancreatoblastoma.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Salkeni isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Adult Soft Tissue SarcomaDr. Salkeni isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Salkeni isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Ampullary CancerDr. Salkeni isExperienced. Learn about Ampullary Cancer.
- Appendix CancerDr. Salkeni isExperienced. Learn about Appendix Cancer.
- AstrocytomaDr. Salkeni isExperienced. Learn about Astrocytoma.